Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.
Clinical trial NCT07369791 · WITHDRAWN
Trial details
- NCT number
- NCT07369791
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2035-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.